Coventry University Featured PhD Programmes
University of Kent Featured PhD Programmes
Catalysis Hub Featured PhD Programmes
University of Liverpool Featured PhD Programmes
Bournemouth University Featured PhD Programmes
"hypertension"×
10 miles

hypertension PhD Projects, Programs & Scholarships

We have 28 hypertension PhD Projects, Programs & Scholarships

  • "hypertension" ×
  • clear all
Order by 
Showing 1 to 10 of 28
  Resistant Hypertension – pathological insights from cardiac microvascular perfusion and mechanics.
  Dr D Oxborough, Prof K George, Prof GYH Lip
Applications accepted all year round
Hypertension commonly predisposes to many cardiovascular complications, including atrial fibrillation, heart failure and stroke. Importantly the heart is responsible for blood pressure yet suffers the consequences of uncontrolled hypertension.
  Translation of Cardiovascular Control Models: Are ‘resistant hypertension’ patients truly drug resistant and does neuronal dysregulation contribute?
  Dr R Barrett-Jolley, Prof GYH Lip, Dr A Shantsila
Applications accepted all year round
Hypertension is major health problem across the world affecting 30-40% of adults, and its prevalence continues to grow, especially in developing countries.
  Role of cytokines in the immunopathogenesis of hypertension
  Research Group: Institute of Cardiovascular and Medical Sciences
  Prof T Guzik, Dr P Maffia, Dr M Kurowska-Stolarska
Application Deadline: 8 May 2019
Applications are invited for a three-year full time PhD studentship within the Institute of Cardiovascular and Medical Sciences.
  Two pore channel segment 2: a new partner in crime for mTORC1 in pulmonary hypertension
  Prof A M Evans
Applications accepted all year round
Mechanistic target of Rapamycin (mTOR) and regulatory protein of TOR (Raptor) complexes (mTORC1) promote idiopathic- and hypoxic pulmonary hypertension (PH), facilitating pulmonary arterial smooth muscle cell (PASMC) growth, proliferation, and thus pulmonary vascular remodelling.
  Study of the osmopressor response in human volunteers with and without hypertension
  Dr M Carew, Dr H Moir
Applications accepted all year round
The osmopressor response refers to the increase in blood pressure and associated change in heart rate that occurs in some people after ingestion of water (1).
  Re-purposing established drugs for the resolution of pulmonary arterial hypertension (PAH)
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim
Applications accepted all year round
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death.
  Therapeutic resolution of pulmonary arterial hypertension (PAH) by natural products
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Prof C Wright
Applications accepted all year round
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death.
  Disturbance of the ‘Cellular uric acid homeostasis’ as the driver for diabetes mellitus, hypertension and cancer
  Dr A Bahn
Applications accepted all year round
My group is interested in how uric acid controls major intracellular metabolic signalling pathways (mTOR, AMPK) in order to understand the onset of diabetes mellitus, hypertension and cancer.
  Modulation of the pulmonary vasculature in health and disease
  Dr D Schwenke
Applications accepted all year round
The pulmonary microcirculation is tightly modulated by the autonomic nervous system, the pulmonary vessel endothelium and the vascular smooth muscle.
  Development of a bedside diagnostic tool to determine low levels of free haemoglobin in whole blood
  Prof A Spivey
Applications accepted all year round
Funded by the CDT in Chemical Biology. Innovation in Life Sciences – 1+3 year PhD studentships. This studentship in the ICB CDT is co-funded with Roche.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.